Four things to know:
1. Zebra-Med’s technology uses algorithms to create 3D models from X-ray images, which surgeons can use during the preoperative surgical planning stage. The technology does not require an MR or CT-based imaging.
2. The partners plan to introduce the technology as part of DePuy Synthes’ VELYS Digital Surgery solution for preoperative, operative and postoperative patient care.
3. Johnson & Johnson Medical Device Cos. introduced the VELYS Digital Surgery platform on Dec. 9, which includes patient solutions and optimization; surgical planning; surgical implementation; and post-op monitoring.
https://www.jnjmedicaldevices.com/en-US/news-events/creating-system-connected-technologies-transform-future-orthopaedic-surgery
4. The agreement is between DePuy Synthes Ireland Unlimited Co. and Zebra Medical Vision.
“We share a common vision surrounding the impact we can have on patients’ lives through the use of AI, and we are happy to initiate such a meaningful strategic partnership, leveraging the tools and knowledge we have built around bone health AI in the last five years,” said Zebra Co-founder and CEO Eyal Gura.
More articles on orthopedics:
49 orthopedic devices receive FDA 510(k) clearance in November
2 recent orthopedic device company acquisitions — November
4 acquisitions that rocked the spine world in the 2010s — and where they are now
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
